PHASE I STUDY OF THE TRIPLE COMBINATION OF UFT/LEUCOVORIN, OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Marsili, Stefania [1 ]
Petrioli, Roberto [1 ]
Sabatino, Marianna [1 ]
Paolelli, Loretta [1 ]
Sciandivasci, Angela [1 ]
Pascucci, Alessandra [1 ]
Ciliberto, Domenico [1 ]
Bindi, Mirco [1 ]
Correale, Pierpaolo [1 ]
Francini, Guido [1 ]
机构：
[1] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancer
    Veronese, ML
    Stevenson, JP
    Sun, W
    Redlinger, M
    Algazy, K
    Giantonio, B
    Hahn, S
    Vaughn, D
    Thorn, C
    Whitehead, AS
    Haller, DG
    O'Dwyer, PJ
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (04) : 508 - 514
  • [22] UFT/leucovorin plus weekly irinotecan in advanced or metastatic colorectal cancer
    Schilling, G
    Lipp, R
    Hegewisch-Becker, S
    Hossfeld, DK
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 38 - 40
  • [23] Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
    Toffoli, Giuseppe
    Cecchin, Erika
    Gasparini, Giampiero
    D'Andrea, Mario
    Azzarello, Giuseppe
    Basso, Umberto
    Mini, Enrico
    Pessa, Sergio
    De Mattia, Elena
    Lo Re, Giovanni
    Buonadonna, Angela
    Nobili, Stefania
    De Paoli, Paolo
    Innocenti, Federico
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 866 - 871
  • [24] Phase I/II study of oral uracil/tegafur (UFT®), leucovorin and irinotecan in patients with advanced colorectal cancer.
    Hill, M
    Mackay, H
    Cunningham, D
    Glasspool, R
    Price, T
    Campbell, S
    Massey, A
    Bailey, S
    Martin, C
    Twelves, C
    ANNALS OF ONCOLOGY, 2000, 11 : 45 - 45
  • [25] Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
    J-P Delord
    J Bennouna
    P Artru
    H Perrier
    F Husseini
    F Desseigne
    E François
    R Faroux
    D Smith
    P Piedbois
    H Naman
    J Y Douillard
    R Bugat
    British Journal of Cancer, 2007, 97 : 297 - 301
  • [26] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Koji Okabayashi
    Hirotoshi Hasegawa
    Yoshiyuki Ishii
    Takashi Endo
    Hiroki Ochiai
    Tetsuro Kubota
    Yuko Kitagawa
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 501 - 507
  • [27] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Okabayashi, Koji
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Endo, Takashi
    Ochiai, Hiroki
    Kubota, Tetsuro
    Kitagawa, Yuko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 501 - 507
  • [28] Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI):: first-line therapy for metastatic colorectal cancer
    Delord, J-P
    Bennouna, J.
    Artru, P.
    Perrier, H.
    Husseini, F.
    Desseigne, F.
    Francois, E.
    Faroux, R.
    Smith, D.
    Piedbois, P.
    Naman, H.
    Douillard, J. Y.
    Bugat, R.
    BRITISH JOURNAL OF CANCER, 2007, 97 (03) : 297 - 301
  • [29] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Meyerhardt, Jeffrey A.
    Clark, Jeffrey W.
    Supko, Jeffrey G.
    Eder, Joseph P.
    Ogino, Shuji
    Stewart, Clinton F.
    D'Amato, Ferdinando
    Dancey, Janet
    Enzinger, Peter C.
    Zhu, Andrew X.
    Ryan, David P.
    Earle, Craig C.
    Mayer, Robert J.
    Michelini, Ann
    Kinsella, Kate
    Fuchs, Charles S.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 661 - 670
  • [30] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Jeffrey A. Meyerhardt
    Jeffrey W. Clark
    Jeffrey G. Supko
    Joseph P. Eder
    Shuji Ogino
    Clinton F. Stewart
    Ferdinando D’Amato
    Janet Dancey
    Peter C. Enzinger
    Andrew X. Zhu
    David P. Ryan
    Craig C. Earle
    Robert J. Mayer
    Ann Michelini
    Kate Kinsella
    Charles S. Fuchs
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 661 - 670
12345